Popular on TelAve
- Parksy (parksy.com) Tackles the Most Common Parking Problem Nobody Talks About: Finding the Car Again - 706
- Sales Blueprint Architect Launches, Helping Sales Professionals, Business Owners, and Consultants Close More Business With AI - 688
- CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards - 584
- New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors - 520
- Fit Body Boot Camp Launches Nationwide 'Fit Body Forever' Workshops to Help Adults 60+ Rebuild Strength and Prevent Falls - 173
- Flexible Plan Investments Announces Retirement of Executive Vice President Renée Toth - 148
- OneVizion Appoints Zebra Technologies CIO Matt Ausman to Board of Directors - 141
- Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd - 125
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 103
- StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
Similar on TelAve
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
- ChargeOn Announces Conversational Payment Management Solution
- VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING
- 54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
- Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
- RAS AP Consulting Signals Growth of Managed AP Governance With Digital Expansion, Pipeline Activation, and Trademark Filing Ahead of Esker All Access
2025 R&D Spending And Intensity Benchmarks
TelAve News/10905878
VIRGINIA BEACH, Va. - TelAve -- Schonfeld & Associates, Inc. has released the latest edition of its annual study R&D Ratios & Budgets. The new research report covers R&D spending and intensity in fiscal 2025 by more than 2,700 individual publicly traded companies within 280 industries. R&D Intensity, a key performance indicator, expresses a company's investment in research and development relative to its revenue. It is defined as the ratio of R&D spending to revenue.
The pharmaceutical industry continues to be the biggest R&D investor in fiscal 2025 with budgets of drug companies increasing slightly to $195 billion. Software companies contributed a total of over $132 billion to this investment pool.
The biggest single R&D investor in 2025 was Amazon at over $108 billion, followed by Alphabet at $61 billion, and then Meta, Microsoft and Apple at over $31 billion each. Firms involved with digital content are investing much more heavily than those in more traditional arenas.
Pharmaceutical firms continued significant R&D spending in 2025. Merck, the top spender at $15.7 billion, is followed by Johnson & Johnson, Astrazeneca, AbbVie, Eli Lilly, Pfizer, and Novartis each spending over $10 billion. The biotech industry, led by Amgen, decreased R&D spending by nearly 8% to $36 billion. Electromedical apparatus makers, led by Medtronic, spent a total of over $3.5 billion, an increase of 2% over 2024.
More on TelAve News
R&D budgets of semiconductor makers grew to over $93 billion, an increase of over 13%. Nvidia had the largest R&D budget, $18 billion, a 43% increase from 2024. Major suppliers to the infrastructure of the Internet cloud continue robust R&D spending to remain competitive.
The 2025 R&D spending of the automotive industry, led by Stellantis, Toyota, Honda, Ford and General Motors each spending over $8 billion, was up over 24% from the 2024 total with industry revenues up over 2%.
R&D Ratios & Budgets is an essential reference presenting R&D spending and intensity information published annually by Schonfeld & Associates, Inc. The study is based on 10-K annual report information submitted to the U.S. Securities & Exchange Commission.
R&D Ratios & Budgets contains information for each of the over 2,700 individual publicly traded companies. Fiscal year 2025 revenue and R&D spending are listed as well as annual growth rates of each. R&D intensity for 2025 is presented along with the lowest and highest R&D Intensity ratio during the past five years. The range of values gives an insight into the stability of the firm's commitment to funding R&D as well as its direction.
More on TelAve News
The industry summary section within R&D Ratios & Budgets presents for each of 280 industries: total fiscal year 2025 revenue and R&D spending as well as annual growth rates of each. The industry R&D intensity ratio for 2025 is listed so that an individual company's value can be compared to the value for the industry as a whole and to answer the question: Is this company leading or lagging its peers in prioritizing innovation?
To allow for further investigation, two Excel datafiles are available for purchase along with the PDF report. Each contains five years of revenue, R&D spending and R&D intensity information. One file contains company data and the other industry information.
The 2026 edition of the R&D Ratios & Budgets PDF study is $395 and the study along with Excel datafiles is $495. Contact Schonfeld & Associates, Inc., 1932 Terramar Lane, Virginia Beach, VA 23456. Call for more information or to place an order: 800-205-0030 or visit https://www.saibooks.com/product/r-d-ratios-budgets-2 for immediate download.
The pharmaceutical industry continues to be the biggest R&D investor in fiscal 2025 with budgets of drug companies increasing slightly to $195 billion. Software companies contributed a total of over $132 billion to this investment pool.
The biggest single R&D investor in 2025 was Amazon at over $108 billion, followed by Alphabet at $61 billion, and then Meta, Microsoft and Apple at over $31 billion each. Firms involved with digital content are investing much more heavily than those in more traditional arenas.
Pharmaceutical firms continued significant R&D spending in 2025. Merck, the top spender at $15.7 billion, is followed by Johnson & Johnson, Astrazeneca, AbbVie, Eli Lilly, Pfizer, and Novartis each spending over $10 billion. The biotech industry, led by Amgen, decreased R&D spending by nearly 8% to $36 billion. Electromedical apparatus makers, led by Medtronic, spent a total of over $3.5 billion, an increase of 2% over 2024.
More on TelAve News
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
- Cruxy shortlisted for two Private Equity Wire® US Awards 2026: Advisory Firm of the Year (Overall) & Value Creation Consulting Firm of the Year
- Lake Norman Philharmonic - Free Community Concert
R&D budgets of semiconductor makers grew to over $93 billion, an increase of over 13%. Nvidia had the largest R&D budget, $18 billion, a 43% increase from 2024. Major suppliers to the infrastructure of the Internet cloud continue robust R&D spending to remain competitive.
The 2025 R&D spending of the automotive industry, led by Stellantis, Toyota, Honda, Ford and General Motors each spending over $8 billion, was up over 24% from the 2024 total with industry revenues up over 2%.
R&D Ratios & Budgets is an essential reference presenting R&D spending and intensity information published annually by Schonfeld & Associates, Inc. The study is based on 10-K annual report information submitted to the U.S. Securities & Exchange Commission.
R&D Ratios & Budgets contains information for each of the over 2,700 individual publicly traded companies. Fiscal year 2025 revenue and R&D spending are listed as well as annual growth rates of each. R&D intensity for 2025 is presented along with the lowest and highest R&D Intensity ratio during the past five years. The range of values gives an insight into the stability of the firm's commitment to funding R&D as well as its direction.
More on TelAve News
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
The industry summary section within R&D Ratios & Budgets presents for each of 280 industries: total fiscal year 2025 revenue and R&D spending as well as annual growth rates of each. The industry R&D intensity ratio for 2025 is listed so that an individual company's value can be compared to the value for the industry as a whole and to answer the question: Is this company leading or lagging its peers in prioritizing innovation?
To allow for further investigation, two Excel datafiles are available for purchase along with the PDF report. Each contains five years of revenue, R&D spending and R&D intensity information. One file contains company data and the other industry information.
The 2026 edition of the R&D Ratios & Budgets PDF study is $395 and the study along with Excel datafiles is $495. Contact Schonfeld & Associates, Inc., 1932 Terramar Lane, Virginia Beach, VA 23456. Call for more information or to place an order: 800-205-0030 or visit https://www.saibooks.com/product/r-d-ratios-budgets-2 for immediate download.
Source: Schonfeld & Associates, Inc.
0 Comments
Latest on TelAve News
- Work 365 Deepens TD SYNNEX Integration with Automated Azure Billing
- RAS AP Consulting Signals Growth of Managed AP Governance With Digital Expansion, Pipeline Activation, and Trademark Filing Ahead of Esker All Access
- Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering
- Steve Thompson Launches StickyHealth to Tackle the Retention Gap in the Growing GLP 1 Market
- Qscription Technologies Appoints Dr. Kimberly Beavers as Founding Clinical Advisor
- When Hope Feels Gone, Death2life Is Still Here!
- Sebastian Stroeller Publishes "The MAP Language Canon" — The Complete Practitioner's Guide to Structural Conversation
- OneVizion Appoints Zebra Technologies CIO Matt Ausman to Board of Directors
- GLADYS Magazine Celebrates their 18 Year Anniversary!
- New Townhome Building Released at Heritage at South Brunswick, Offering Private Perimeter Setting and Water Views
- Comics Veteran on Return of Teenage Mutant Ninja Turtles Characters, 3-D Projects, Collaboration with Original 'Star Wars' Toy Engineer
- Flexible Plan Investments Announces Retirement of Executive Vice President Renée Toth
- Sensory Education launches new neuro-affirming psychoeducation book, Sensory Diversity
- SafecomLink for Pactor – Hamradio Edition Launches in the WiMo Store
- Break the Resume Mold: Career Valet Changes How Executives Hunt for Jobs
- James Dooley Named King of AEO at Ceremony in Leigh, England
- Calling all healthcare process experts: Share your ideas at #HSPI2027 in Orlando
- Central Bag Company Partners with WYSIWYG Marketing and Launches a Modern Industrial Website
- DuoKey launches the World's First Agentic Crypto Agility Platform
- Counterparts Exhibition - Art is Destiny!
